More good news about angiogenesis inhibitors
Massachusetts General Hospital researchers used an anti-angiogenesis agent to reduce the size of brain tumors called glioblastomas. This is the most malignant form of brain cancer, and this success gives hope for people with this form of cancer and, more broadly, for the cancer research community which has been interested in angiogenesis inhibitors. Many such drugs are in trials; they work by preventing the growth of blood vessels and thereby preventing tumors from getting larger.
